
08/12/2025
Scripx Pharmacy is proud to announce that we are now an approved pharmacy with the LDN Research Trust, Low Dose Naltrexone, a significant milestone that underscores our commitment to advancing access, quality, and research in (LDN) therapy.
LDN is increasingly recognized in functional and integrative medicine for its potential benefits in , , inflammation, and more. Being an approved LDN Research Network pharmacy means meets stringent quality, safety, and reliability standards that physicians and patients can trust.
What sets Scripx apart:
1️⃣ Pharmaceutical-grade quality: Every batch of LDN is independently third-party tested for potency, purity, and consistency.
2️⃣ -Accredited: Recognized for meeting the highest compounding pharmacy standards in the U.S.
3️⃣ National reach: Licensed in multiple states, giving providers and patients expanded access to quality LDN.
4️⃣ Trusted partnerships: Proud members of PCCA, , and the National Community Pharmacists Association (NCPA).
5️⃣ Research support: Collaborating with the LDN Research Trust and engaged in discussions around ongoing and future clinical trials.
For & Providers:
Working with Scripx means your patients have a pharmacy partner that understands the precision, safety, and therapeutic potential of LDN. We are dedicated to supporting your practice with customized formulations and a streamlined patient experience. Total Men's Primary Care
📌 Providers and patients can now access our LDN services through the LDN Research Network, ensuring confidence in both product quality and professional expertise. Functional Medicine University Holistic Functional Nutritionist